Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis-Reference-Cited by-同舟云学术

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

Published:2020-06 Issue:8 Volume:158 Page:2139-2149.e14
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sandborn William J.,Ghosh Subrata^ORCID,Panes Julian^ORCID,Schreiber Stefan,D’Haens Geert,Tanida Satoshi^ORCID,Siffledeen Jesse,Enejosa Jeffrey,Zhou Wen,Othman Ahmed A.^ORCID,Huang Bidan,Higgins Peter D.R.^ORCID

Funder

Atlantic Healthcare Limited

Amgen

Genentech

Gilead Sciences

AbbVie

Janssen

Takeda

Lilly

Celgene

Receptos

Pfizer

Prometheus Laboratories

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

2. Self-reported symptom burden in individuals with inflammatory bowel disease;Farrell;J Crohns Colitis,2016

3. Correlation between physician and patient disease assessments in ulcerative colitis: baseline data from the ICONIC study of 1816 patients in 33 countries;Ghosh;J Crohns Colitis,2017

4. IBD and health-related quality of life — discovering the true impact;Lonnfors;J Crohns Colitis,2014

5. Ulcerative colitis;Ordas;Lancet,2012

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib;Digestive Diseases and Sciences;2024-09-09

2. Risk of nonmelanoma skin cancer in patients taking Janus kinase inhibitors for inflammatory bowel disease: A systematic review and meta-analysis;Dermatologica Sinica;2024-09-04

3. Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators;The Korean Journal of Gastroenterology;2024-08-25

4. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus;Digestive and Liver Disease;2024-08

5. Small molecules for inflammatory bowel disease and the risk of infection and malignancy: A systematic review and meta-Analysis;Digestive and Liver Disease;2024-08